human leukocyte antigen
Showing 26 - 50 of >10,000
Resected Pancreatic Adenocarcinoma
Completed
- Pancreatic Cancer Resectable
- Multigene panel for next-generation sequencing
-
Shanghai, Shanghai, ChinaRuijin Hospital
Jul 31, 2022
Sars-CoV-2 Infection, COVID-19 Trial in Knoxville (Rapid SARS-CoV-2 Antigen Test)
Completed
- Sars-CoV-2 Infection
- COVID-19
- Rapid SARS-CoV-2 Antigen Test
-
Knoxville, TennesseeEDP Biotech Corporation
Oct 14, 2022
Renal Cell Carcinoma, NSCLC, Pancreatic Adenocarcinoma, Colorectal Cancer Trial (RO7515629, tocilizumab)
Not yet recruiting
- Renal Cell Carcinoma, Non-small Cell Lung Cancer, Pancreatic Adenocarcinoma, Colorectal Cancer
- (no location specified)
Mar 3, 2023
Roles of Some Non-classic Biomarkers in Pediatric Pneumonia
Not yet recruiting
- Pneumonia in Children
- (no location specified)
Jan 25, 2023
Warts, Human Papilloma Virus Trial in Zagazig (Candida antigen vaccine, Bivalent HPV vaccine)
Recruiting
- Warts
- Human Papilloma Virus
- Candida antigen vaccine
- Bivalent HPV vaccine
-
Zagazig, Al Sharqia, EgyptReham Essam
Jul 26, 2022
Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia Trial in Cleveland (Fully human anti CD19 CAR-T
Recruiting
- Non Hodgkin Lymphoma
- +2 more
- Fully human anti CD19 CAR-T Cell Dose
- +2 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Oct 4, 2022
Lupus Nephritis, Lupus Nephritis - World Health Organization (WHO) Class III, Lupus Nephritis - WHO Class IV Trial in Denver,
Recruiting
- Lupus Nephritis
- +2 more
- KYV-101 anti-CD19 CAR-T cell therapy
- Standard lymphodepletion regimen
-
Denver, Colorado
- +1 more
Jul 7, 2023
Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto
Not yet recruiting
- Multiple Sclerosis
- +2 more
- KYV-101 anti-CD19 CAR-T cell therapy
- Standard lymphodepletion regimen
-
Palo Alto, CaliforniaStanford Multiple Sclerosis Center
Nov 13, 2023
Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)
Not yet recruiting
- Chronic Graft Versus Host Disease
- +2 more
- Biopsy
- +11 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 7, 2023
Phase Angle and Chronic Intestinal Inflammatory Diseases
Recruiting
- Inflammatory Bowel Diseases
- +3 more
-
Bari, BA, ItalyMichele Barone
May 17, 2022
Solid Tumor Trial (HER2-E-CART cells)
Not yet recruiting
- Solid Tumor
- HER2-E-CART cells
- (no location specified)
Feb 16, 2023
Acute Respiratory Distress Syndrome Trial (Racecadotril 100 milligram (MG) Oral Capsule, Placebo)
Not yet recruiting
- Acute Respiratory Distress Syndrome
- Racecadotril 100 milligram (MG) Oral Capsule
- Placebo
- (no location specified)
Jan 13, 2023
Acute Leukemias, Burkitt's Lymphoma, Chronic Myelogenous Leukemia Trial in Minneapolis (drug, radiation, biological)
Terminated
- Acute Leukemias
- +2 more
- Fludarabine
- +3 more
-
Minneapolis, MinnesotaUniversity of Minnesota Masonic Cancer Center
Dec 12, 2019
Head Neck Cancer, Cervical Cancer, Non-small Cell Carcinoma Trial in Scottsdale, Chapel Hill (TSC-204-A0201, TSC-204-C0702,
Not yet recruiting
- Head and Neck Cancer
- +20 more
- TSC-204-A0201
- +4 more
-
Scottsdale, Arizona
- +1 more
Aug 3, 2023
The Effect of Human Prostate Tissue on Platelet Activation
Completed
- Prostate Hyperplasia
- +2 more
- (no location specified)
Sep 19, 2021
Ewing Sarcoma, Rhabdomyosarcoma, Synovial Sarcoma Trial in Frankfurt am Main, Freiburg, Tübingen (Peptide vaccine IPX)
Recruiting
- Ewing Sarcoma
- +2 more
- Peptide vaccine IPX
-
Frankfurt am Main, Germany
- +2 more
Oct 18, 2023
Idiopathic Inflammatory Myopathies, Diffuse Cutaneous Systemic Sclerosis, SLE Nephritis Trial (KYV-101, Cyclophosphamide,
Not yet recruiting
- Idiopathic Inflammatory Myopathies
- +3 more
- KYV-101
- +2 more
- (no location specified)
Nov 21, 2023
Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From
Completed
- Covid19
- Nanomix eLab® COVID-19 Rapid Antigen Panel (non-interventional)
-
Emeryville, CaliforniaNanomix
Dec 22, 2021
Antibody-mediated Rejection, Cardiac Transplant Trial in Rochester (Daratumumab and hyaluronidase-fihj)
Enrolling by invitation
- Antibody-mediated Rejection
- Cardiac Transplant
- Daratumumab and hyaluronidase-fihj
-
Rochester, MinnesotaMayo Clinic Rochester
Apr 11, 2022
Lymphoma, B-Cell, Lymphoma, Non-hodgkins, Chronic Lymphocytic Leukemia Trial run by the NCI (Anti-cluster of differentiation 19
Terminated
- Lymphoma, B-Cell
- +3 more
- Anti-cluster of differentiation 19 (CD19)-Chimeric Antigen Receptors (CAR) and Anti-cluster of differentiation 20 (CD20)-CAR T cells
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2022
Hematologic Malignancies Trial in Minneapolis (Haplo HCT <55 years old, Haplo HCT =55 years old, GVHD Prophylaxis)
Recruiting
- Hematologic Malignancies
- Haplo HCT <55 years old
- +4 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Jan 25, 2023
SARS CoV 2 Infection, Influenza, Human Trial in Spain (BIMERVAX, SIIV)
Not yet recruiting
- SARS CoV 2 Infection
- Influenza, Human
- BIMERVAX
- SIIV
-
Santiago De Compostela, A Coruña, Spain
- +7 more
Aug 8, 2023
Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))
Recruiting
- Hematologic Malignancy
- Myeloid Malignancy
- Ruxolitinib
- +10 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Nov 7, 2022